|Bid||21.40 x 100000|
|Ask||22.20 x 100000|
|Day's Range||20.98 - 20.98|
|52 Week Range||8.40 - 24.06|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 22, 2023 - Feb 27, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for O2T.SG
PARSIPPANY, N.J., December 02, 2022--Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to nine newly-hired, non-executive employees.
PARSIPPANY, N.J., December 01, 2022--Iveric Bio announced the pricing of an upsized underwritten public offering of 13,350,000 shares of its common stock at a price of $22.50 per share.
PARSIPPANY, N.J., November 30, 2022--Iveric Bio today announced that it is commencing an underwritten public offering of $250.0 million of shares of its common stock.